From the Division of neonatology, Department of Pediatrics, School of Medicine, University of California Davis, Sacramento, California.
Department of Microbiology and Immunology, School of Medicine, University of California Davis, Davis, California.
Pediatr Infect Dis J. 2019 Jul;38(7):682-686. doi: 10.1097/INF.0000000000002285.
In adults, Staphylococcus epidermidis and Staphylococcus aureus compete for colonization of the nasal mucosa and S. epidermidis strains that produce the Esp serine protease eradicate S. aureus nasal colonization. Whether similar phenomena are seen in newborn infants is unknown.
Nasal swabs were obtained on admission and discharge from newborn infants (n = 90 and 83, respectively) in the neonatal intensive care unit at UC Davis Children's Hospital. Swabs were cultured for S. aureus and S. epidermidis. S. epidermidis isolates were tested for Esp expression, overall secreted protease activity and biofilm inhibition.
No infant had S. aureus on admission. S. epidermidis colonization was rare on admission in inborn infants (2.5%), but common in infants transferred from referring hospitals (50%). At discharge, most infants (96%) were colonized by staphylococci. S. aureus colonization was less common in infants with S. epidermidis colonization (9%) and more common in infants without S. epidermidis (77%) (relative risk of S. aureus colonization in infants colonized with S. epidermidis 0.18, 95% confidence interval: 0.089-0.34, P < 0.0001). Compared with S. epidermidis strains from infants without S. aureus, S. epidermidis from infants co-colonized with S. aureus had lower total proteolytic enzyme activity and decreased biofilm inhibition capacity, but did not have lower frequency of Esp positivity.
In hospitalized neonates, S. epidermidis colonization has a protective effect against S. aureus colonization. Secretion of proteases by S. epidermidis is a possible mechanism of inhibition of S. aureus colonization; however, in this cohort of neonates, the source of major protease activity is likely other than Esp.
在成年人中,表皮葡萄球菌和金黄色葡萄球菌竞争定植于鼻腔黏膜,产生 Esp 丝氨酸蛋白酶的表皮葡萄球菌菌株可消除金黄色葡萄球菌的鼻腔定植。在新生儿中是否存在类似现象尚不清楚。
在加利福尼亚大学戴维斯分校儿童医院新生儿重症监护病房,分别于新生儿入院时(n=90)和出院时(n=83)采集鼻拭子。培养拭子以鉴定金黄色葡萄球菌和表皮葡萄球菌。检测表皮葡萄球菌分离株的 Esp 表达、总分泌蛋白酶活性和生物膜抑制情况。
入院时无婴儿携带金黄色葡萄球菌。在出生婴儿中,表皮葡萄球菌定植在入院时罕见(2.5%),但在从转诊医院转来的婴儿中常见(50%)。出院时,大多数婴儿(96%)定植有葡萄球菌。与表皮葡萄球菌定植的婴儿相比,金黄色葡萄球菌定植的婴儿较少(9%),而无表皮葡萄球菌定植的婴儿较多(77%)(表皮葡萄球菌定植婴儿中金黄色葡萄球菌定植的相对风险为 0.18,95%置信区间:0.089-0.34,P<0.0001)。与无金黄色葡萄球菌定植的婴儿的表皮葡萄球菌株相比,与金黄色葡萄球菌共同定植的婴儿的表皮葡萄球菌株总蛋白水解酶活性较低,生物膜抑制能力降低,但 Esp 阳性率无差异。
在住院新生儿中,表皮葡萄球菌定植对金黄色葡萄球菌定植具有保护作用。表皮葡萄球菌分泌的蛋白酶可能是抑制金黄色葡萄球菌定植的机制之一;然而,在本队列的新生儿中,主要蛋白酶活性的来源可能不是 Esp。